Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 690Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8APOTEX INC

02 15ELVIUM LIFE SCIENCES

03 4JANSSEN INC

04 3KYE PHARMACEUTICALS INC.

05 11PHARMASCIENCE INC

06 7Pharmascience Inc.

07 4TEVA CANADA LIMITED

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE TABLETS 10MG

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

02

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE TABLETS 20MG

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

03

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

04

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 18MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

05

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 27MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

06

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 36MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

07

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

Methylphenidate Hydrochloride

Brand Name : PMS-METHYLPHENIDATE ER

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 54MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

08

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100/500

Approval Date :

Application Number : 584991

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

09

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 100

Approval Date :

Application Number : 585009

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank

10

CPhI India 2024
Not Confirmed
arrow
arrow
CPhI India 2024
Not Confirmed

METHYLPHENIDATE HYDROCHLORIDE

Brand Name : PMS-METHYLPHENIDATE

Dosage Form : TABLET

Dosage Strength : 5MG

Packaging : 100/500

Approval Date :

Application Number : 2234749

Regulatory Info : Schedule G (CDSA III)

Registration Country : Canada

blank